ID   RPC5_HUMAN              Reviewed;         708 AA.
AC   Q9NVU0; B4DL24; B4DUP6; H3BT11; Q9BWF7; Q9H8W8; Q9H907; Q9P276;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 140.
DE   RecName: Full=DNA-directed RNA polymerase III subunit RPC5;
DE            Short=RNA polymerase III subunit C5;
DE   AltName: Full=DNA-directed RNA polymerase III 80 kDa polypeptide;
GN   Name=POLR3E; Synonyms=KIAA1452;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION IN THE RNA POL
RP   III COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH
RP   POLR3D.
RX   PubMed=12391170; DOI=10.1128/MCB.22.22.8044-8055.2002;
RA   Hu P., Wu S., Sun Y., Yuan C.-C., Kobayashi R., Myers M.P.,
RA   Hernandez N.;
RT   "Characterization of human RNA polymerase III identifies orthologues
RT   for Saccharomyces cerevisiae RNA polymerase III subunits.";
RL   Mol. Cell. Biol. 22:8044-8055(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 4 AND 5).
RC   TISSUE=Teratocarcinoma, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-522, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=19631370; DOI=10.1016/j.cell.2009.06.015;
RA   Chiu Y.-H., Macmillan J.B., Chen Z.J.;
RT   "RNA polymerase III detects cytosolic DNA and induces type I
RT   interferons through the RIG-I pathway.";
RL   Cell 138:576-591(2009).
RN   [9]
RP   FUNCTION.
RX   PubMed=19609254; DOI=10.1038/ni.1779;
RA   Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A.,
RA   Hornung V.;
RT   "RIG-I-dependent sensing of poly(dA:dT) through the induction of an
RT   RNA polymerase III-transcribed RNA intermediate.";
RL   Nat. Immunol. 10:1065-1072(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; TYR-224 AND
RP   SER-503, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; SER-162 AND
RP   SER-503, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192 AND SER-503, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161 AND SER-162, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-498 AND LYS-659, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-498, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-659, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-659, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. Specific peripheric component of RNA polymerase III
CC       which synthesizes small RNAs, such as 5S rRNA and tRNAs. Essential
CC       for efficient transcription from both the type 2 VAI and type 3 U6
CC       RNA polymerase III promoters. Plays a key role in sensing and
CC       limiting infection by intracellular bacteria and DNA viruses. Acts
CC       as nuclear and cytosolic DNA sensor involved in innate immune
CC       response. Can sense non-self dsDNA that serves as template for
CC       transcription into dsRNA. The non-self RNA polymerase III
CC       transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs)
CC       induce type I interferon and NF- Kappa-B through the RIG-I pathway
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:19609254,
CC       ECO:0000269|PubMed:19631370}.
CC   -!- SUBUNIT: Component of the RNA polymerase III (Pol III) complex
CC       consisting of 17 subunits (By similarity). Interacts with
CC       POLR3D/RPC4. {ECO:0000250, ECO:0000269|PubMed:12391170}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9NVU0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NVU0-2; Sequence=VSP_007065;
CC       Name=3;
CC         IsoId=Q9NVU0-3; Sequence=VSP_007064;
CC         Note=No experimental confirmation available. May result from the
CC         retention of an intron in the cDNA.;
CC       Name=4;
CC         IsoId=Q9NVU0-4; Sequence=VSP_044710;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q9NVU0-5; Sequence=VSP_046374;
CC         Note=No experimental confirmation available.;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA95976.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB14481.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY092085; AAM18215.1; -; mRNA.
DR   EMBL; AB040885; BAA95976.1; ALT_INIT; mRNA.
DR   EMBL; AK001371; BAA91655.1; -; mRNA.
DR   EMBL; AK023160; BAB14437.1; -; mRNA.
DR   EMBL; AK023231; BAB14481.1; ALT_INIT; mRNA.
DR   EMBL; AK296813; BAG59386.1; -; mRNA.
DR   EMBL; AK300735; BAG62408.1; -; mRNA.
DR   EMBL; AC009034; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092338; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000285; AAH00285.1; -; mRNA.
DR   CCDS; CCDS10605.1; -. [Q9NVU0-1]
DR   CCDS; CCDS58432.1; -. [Q9NVU0-4]
DR   CCDS; CCDS58433.1; -. [Q9NVU0-2]
DR   CCDS; CCDS58434.1; -. [Q9NVU0-5]
DR   RefSeq; NP_001244962.1; NM_001258033.1. [Q9NVU0-4]
DR   RefSeq; NP_001244963.1; NM_001258034.1. [Q9NVU0-5]
DR   RefSeq; NP_001244964.1; NM_001258035.1.
DR   RefSeq; NP_001244965.1; NM_001258036.1. [Q9NVU0-2]
DR   RefSeq; NP_060589.1; NM_018119.3. [Q9NVU0-1]
DR   RefSeq; XP_006721126.1; XM_006721063.2. [Q9NVU0-1]
DR   RefSeq; XP_006726676.1; XM_006726613.1. [Q9NVU0-1]
DR   UniGene; Hs.460298; -.
DR   ProteinModelPortal; Q9NVU0; -.
DR   BioGrid; 120840; 52.
DR   BioGrid; 3190820; 9.
DR   IntAct; Q9NVU0; 39.
DR   MINT; MINT-3075248; -.
DR   STRING; 9606.ENSP00000299853; -.
DR   iPTMnet; Q9NVU0; -.
DR   PhosphoSitePlus; Q9NVU0; -.
DR   BioMuta; POLR3E; -.
DR   DMDM; 29428028; -.
DR   EPD; Q9NVU0; -.
DR   MaxQB; Q9NVU0; -.
DR   PaxDb; Q9NVU0; -.
DR   PeptideAtlas; Q9NVU0; -.
DR   PRIDE; Q9NVU0; -.
DR   Ensembl; ENST00000299853; ENSP00000299853; ENSG00000058600. [Q9NVU0-1]
DR   Ensembl; ENST00000359210; ENSP00000352140; ENSG00000058600. [Q9NVU0-2]
DR   Ensembl; ENST00000418581; ENSP00000399254; ENSG00000058600. [Q9NVU0-5]
DR   Ensembl; ENST00000564209; ENSP00000456967; ENSG00000058600. [Q9NVU0-4]
DR   GeneID; 101060521; -.
DR   GeneID; 55718; -.
DR   KEGG; hsa:101060521; -.
DR   KEGG; hsa:55718; -.
DR   UCSC; uc002dkk.5; human. [Q9NVU0-1]
DR   CTD; 55718; -.
DR   DisGeNET; 101060521; -.
DR   DisGeNET; 55718; -.
DR   GeneCards; POLR3E; -.
DR   HGNC; HGNC:30347; POLR3E.
DR   HPA; HPA041419; -.
DR   HPA; HPA041477; -.
DR   neXtProt; NX_Q9NVU0; -.
DR   OpenTargets; ENSG00000058600; -.
DR   PharmGKB; PA134964025; -.
DR   eggNOG; KOG2354; Eukaryota.
DR   eggNOG; ENOG410Y1X8; LUCA.
DR   GeneTree; ENSGT00390000016123; -.
DR   HOGENOM; HOG000069875; -.
DR   HOVERGEN; HBG039706; -.
DR   InParanoid; Q9NVU0; -.
DR   KO; K14721; -.
DR   OMA; KGWEFIL; -.
DR   OrthoDB; EOG091G0BTS; -.
DR   PhylomeDB; Q9NVU0; -.
DR   TreeFam; TF103050; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   ChiTaRS; POLR3E; human.
DR   GeneWiki; POLR3E; -.
DR   PRO; PR:Q9NVU0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000058600; -.
DR   CleanEx; HS_POLR3E; -.
DR   ExpressionAtlas; Q9NVU0; baseline and differential.
DR   Genevisible; Q9NVU0; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005666; C:DNA-directed RNA polymerase III complex; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0006383; P:transcription from RNA polymerase III promoter; IEA:GOC.
DR   InterPro; IPR006886; RNA_pol_III_Rpc5.
DR   PANTHER; PTHR12069:SF1; PTHR12069:SF1; 1.
DR   Pfam; PF04801; Sin_N; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiviral defense; Complete proteome;
KW   DNA-directed RNA polymerase; Immunity; Innate immunity;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Ubl conjugation.
FT   CHAIN         1    708       DNA-directed RNA polymerase III subunit
FT                                RPC5.
FT                                /FTId=PRO_0000073970.
FT   MOD_RES     161    161       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     192    192       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     224    224       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     503    503       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CROSSLNK    498    498       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    498    498       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    659    659       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364}.
FT   VAR_SEQ      13     48       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046374.
FT   VAR_SEQ     623    708       FPPQTAASPDEQKVFALWESGDMSDQHRQVLLEIFSKNYRV
FT                                RRNMIQSRLTQECGEDLSKQEVDKVLKDCCVSYGGMWYLKG
FT                                TVQS -> VSRALPARGMGGGGWGEPAVGRPRGDTGGHAW
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:10819331}.
FT                                /FTId=VSP_007064.
FT   VAR_SEQ     648    668       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044710.
FT   VAR_SEQ     649    690       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007065.
FT   VARIANT      46     46       S -> A (in dbSNP:rs2347).
FT                                /FTId=VAR_024623.
FT   CONFLICT     14     14       D -> N (in Ref. 2; BAB14437).
FT                                {ECO:0000305}.
FT   CONFLICT     80     80       N -> D (in Ref. 3; BAG62408).
FT                                {ECO:0000305}.
FT   CONFLICT    148    148       K -> E (in Ref. 2; BAB14437).
FT                                {ECO:0000305}.
FT   CONFLICT    316    316       K -> Q (in Ref. 1; AAM18215).
FT                                {ECO:0000305}.
SQ   SEQUENCE   708 AA;  79898 MW;  E9DB71615CC367A5 CRC64;
     MANEEDDPVV QEIDVYLAKS LAEKLYLFQY PVRPASMTYD DIPHLSAKIK PKQQKVELEM
     AIDTLNPNYC RSKGEQIALN VDGACADETS TYSSKLMDKQ TFCSSQTTSN TSRYAAALYR
     QGELHLTPLH GILQLRPSFS YLDKADAKHR EREAANEAGD SSQDEAEDDV KQITVRFSRP
     ESEQARQRRV QSYEFLQKKH AEEPWVHLHY YGLRDSRSEH ERQYLLCPGS SGVENTELVK
     SPSEYLMMLM PPSQEEEKDK PVAPSNVLSM AQLRTLPLAD QIKILMKNVK VMPFANLMSL
     LGPSIDSVAV LRGIQKVAML VQGNWVVKSD ILYPKDSSSP HSGVPAEVLC RGRDFVMWKF
     TQSRWVVRKE VATVTKLCAE DVKDFLEHMA VVRINKGWEF ILPYDGEFIK KHPDVVQRQH
     MLWTGIQAKL EKVYNLVKET MPKKPDAQSG PAGLVCGDQR IQVAKTKAQQ NHALLERELQ
     RRKEQLRVPA VPPGVRIKEE PVSEEGEEDE EQEAEEEPMD TSPSGLHSKL ANGLPLGRAA
     GTDSFNGHPP QGCASTPVAR ELKAFVEATF QRQFVLTLSE LKRLFNLHLA SLPPGHTLFS
     GISDRMLQDT VLAAGCKQIL VPFPPQTAAS PDEQKVFALW ESGDMSDQHR QVLLEIFSKN
     YRVRRNMIQS RLTQECGEDL SKQEVDKVLK DCCVSYGGMW YLKGTVQS
//
